36C25725N0190↗
Novartis Pharmaceuticals Corporation received this contract from 257-Network Contract Office 17 (36C257), Department of Veterans Affairs: $2.67M obligated so far for drugs and biologicals. Its period of performance ended 2026-02-06.
Key facts · data as of Oct 26, 2026
- Recipient
- Novartis Pharmaceuticals Corporation
- Awarding agency
- Department of Veterans Affairs
- Contracting office
- 257-Network Contract Office 17 (36C257) (36C257)
- Obligated to date
- $2.67M
- Potential value
- $2.67M
- Ends
- 2026-02-06
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 36C25725N0190, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_36C25725N0190_3600_36F79720D0180_3600
Novartis Pharmaceuticals Corporation: all federal awards · Department of Veterans Affairs: spending · 257-Network Contract Office 17 (36C257): what it buys
LUTATHERA & PLUVICTO
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- 257-Network Contract Office 17 (36C257) (36C257)
- Competition
- Full and open competition · 1 offer received
- Pricing
- Firm fixed price
- How it was bought
- GSA Schedule · under 36F79720D0180
- Where the work is
- Morris, NJ · district NJ-11
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
3 actions since 2025-02-07. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-04-16 | P00002 | Supplemental agreement (work within scope) | $34.3K | LUTATHERA & PLUVICTO - INCREASE QUANTITY +1 |
| 2026-03-24 | P00001 | Funding only | -$1.47M | LUTATHERA & PLUVICTO - DE-OBLIGATE EXCESS FUNDS |
| 2025-02-07 | 0 | $4.11M | LUTATHERA & PLUVICTO |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗